09:50 AM EST - Valeant Pharmaceuticals International, Inc. : Announced that Paul S. Herendeen has been appointed Executive Vice President, Finance and will take over the role of Chief Financial Officer from Robert L. Rosiello effective immediately. Rosiello will remain at Valeant as Executive Vice President, Corporate Development and Strategy. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $2.01 at $38.97.
